Dr. med. Ansgar Felbecker
chief of service
Neurologie · Dept. III
CELIA (Phase 2)
Mar 1, 2024A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age
Clinical Studies - Mar 1, 2024 - Dec 31, 2026
Ongoing
Project leader: Felbecker Ansgar
Members: Göhl-Freyn Kristina
Memory Clinic Cohort Study
Mar 1, 2024Dementia is a clinical syndrome defined by a progressive cognitive decline interfering with a person's daily life and activities which is caused by a group of heterogenous neurodegenerative and neurovascular diseases which often overlap. Since patho...
Clinical Studies - Mar 1, 2024 - Dec 31, 2040
Ongoing
Project leader: Schneider Thomas, Felbecker Ansgar
Members: Göhl-Freyn Kristina, Schilg-Hafer Lenka
Inflammatory Neuropathy Consortium Base (INCbase
Dec 15, 2021The Inflammatory Neuropathy Consortium Base (INCbase) is an international registry for CIDP patients led by an international collaboration of CIDP experts. INCbase provides a state of the art modular research database that members may use to collect...
Fundamental Research - Dec 15, 2021 - Dec 15, 2025
Ongoing
Members: Felbecker Ansgar, Leupold Daniela
Cognitive Outcome 1 year after COVID-19 – A Pilot Study (CogCOVID)
Oct 19, 2021This prospective observational pilot study examines cognitive function 1 year after SARS-Cov-2 disease. Study population consists of formerly hospitalized non-ventilated COVID-19 patients (nvCOVID) and ventilated patients with COVID-19-ARDS (cARDS) t...
Clinical Studies - Oct 19, 2021 - Dec 31, 2022
Automatically Closed
Project leader: Göhl-Freyn Kristina, Felbecker Ansgar
Members: Albrich Werner, Schmid Dagmar, Kleger Gian-Reto, Schrag Claudia, Pietsch Urs
EVOKE
Sep 30, 2021A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) This study is done to find out whether semaglutide has a positive effect on early Alzheimer's disease. Participants will either get semaglutide or placebo - w...
Clinical Studies - Sep 30, 2021 - Dec 31, 2025
Ongoing
Project leader: Felbecker Ansgar
Pilot study on cognitive and social function measures for early detection of progressive neurocognitive disorders in Switzerland
May 12, 2021
Clinical Studies - May 12, 2021 - Sep 15, 2022
Completed
Project leader: Felbecker Ansgar
Development of a non-invasive screening system for the early detection of mild cognitive impairments in older adults
Nov 1, 2020In dem geförderten Kooperationsprojekt “Development of a non-invasive screening system for the early detection of mild cognitive impairments in older adults” wird untersucht, ob ein multimodales nicht-invasives Testsystem geeignet ist, um frühe Stadi...
Clinical Studies - Nov 1, 2020 - Jul 1, 2021
Automatically Closed
Project leader: Felbecker Ansgar
Members: Schneider Thomas
CRiPSI/CRiPSI-X: Covid-19 Risk Prediction in Swiss ICUs-Trial/Extension
Aug 1, 2020Outcome of patients with critical Covid-19 varies. We study risk of and predictors for poor outcome in adult patients with Covid-19 admitted to ICU in a multicenter study. In addition, we assess the prevalence of, risk factors for and mechanisms invo...
Clinical Studies - Aug 1, 2020 - Aug 31, 2022
Automatically Closed
Project leader: Albrich Werner
Members: Von Mering Christian, O'Mahony Liam, Cerny Andreas, Suh Noémie, El Baz Yassir, Dietrich Tobias, Fischer Tim, Felbecker Ansgar, Göhl-Freyn Kristina, Germann Nicolas, Schmid Dagmar, Kahlert Christian, Frischknecht Manuel, Filipovic Miodrag, Brutsche Martin, Pietsch Urs, Kleger Gian-Reto, Bochud Pierre-Yves
A3BAD study - Analysis of amyloid aggregates in blood with atomic force microscopy as a biomarker of Alzheimer Dementia
Jun 1, 2020Background: The key neuropathological feature of Alzheimer disease (AD) is the accumulation of extracellular β-amyloid (Aβ) plaques in the brain which begins long before clinical signs of dementia. Immunotherapies targeting Aβ may prevent Aβ accumula...
Fundamental Research - Jun 1, 2020 - May 30, 2022
Automatically Closed
Project leader: Felbecker Ansgar
Members: Schneider Thomas, Nirmjaraj Peter
Randomisierte, doppelblinde, placebokontrollierte klinische Prüfung der Phase III mit Parallelgruppen zur Beurteilung der Wirksmkeit und Sicherheit von Desmoteplase bei Patienten mit akuten ischämischem Schlaganfall DIAS III
Mar 12, 2010Multizentrische Therapiestudie zur Anwednung von Desmoteplase
Clinical Studies - Mar 12, 2010 - Dec 31, 2012
Aborted
Project leader: Weder Bruno, Kägi Georg
Members: Hundsberger Thomas, Felbecker Ansgar, Hägele-Link Stefan, Galovic Marian, Leupold Daniela